- Divakaruni, Ajit S;
- Hsieh, Wei Yuan;
- Minarrieta, Lucía;
- Duong, Tin N;
- Kim, Kristen KO;
- Desousa, Brandon R;
- Andreyev, Alexander Y;
- Bowman, Caitlyn E;
- Caradonna, Kacey;
- Dranka, Brian P;
- Ferrick, David A;
- Liesa, Marc;
- Stiles, Linsey;
- Rogers, George W;
- Braas, Daniel;
- Ciaraldi, Theodore P;
- Wolfgang, Michael J;
- Sparwasser, Tim;
- Berod, Luciana;
- Bensinger, Steven J;
- Murphy, Anne N
Long-chain fatty acid (LCFA) oxidation has been shown to play an important role in interleukin-4 (IL-4)-mediated macrophage polarization (M(IL-4)). However, many of these conclusions are based on the inhibition of carnitine palmitoyltransferase-1 with high concentrations of etomoxir that far exceed what is required to inhibit enzyme activity (EC90 < 3 μM). We employ genetic and pharmacologic models to demonstrate that LCFA oxidation is largely dispensable for IL-4-driven polarization. Unexpectedly, high concentrations of etomoxir retained the ability to disrupt M(IL-4) polarization in the absence of Cpt1a or Cpt2 expression. Although excess etomoxir inhibits the adenine nucleotide translocase, oxidative phosphorylation is surprisingly dispensable for M(IL-4). Instead, the block in polarization was traced to depletion of intracellular free coenzyme A (CoA), likely resulting from conversion of the pro-drug etomoxir into active etomoxiryl CoA. These studies help explain the effect(s) of excess etomoxir on immune cells and reveal an unappreciated role for CoA metabolism in macrophage polarization.